9-β-D-arabinofuranosyladenine 5′-monophosphate (araAMP) is converted directly to its antivirally active 5′-triphosphate form by 5-phosphoribosyl-1-pyrophosphate (PRPP) synthetase
- 1 December 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 173 (3) , 781-787
- https://doi.org/10.1016/s0006-291x(05)80855-1
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cellsBiochemical Pharmacology, 1984
- The Enzymatic Synthesis of 5-Amino-4-Imidazolecarboxamide Riboside Triphosphate (ZTP)Science, 1984
- Vidarabine (Vira-A®): Pharmacology and clinical experiencePharmacology & Therapeutics, 1980
- VidarabineDrugs, 1980
- INHIBITION OF HERPESVIRUS DNA SYNTHESIS BY 9‐β‐D‐ARABINOFURANOSYLADENINE IN CELLULAR AND CELL‐FREE SYSTEMS *Annals of the New York Academy of Sciences, 1977
- Analysis by high-pressure liquid chromatography of 9-β-d-arabinofuranosyladenine 5′-triphosphate levels in murine leukemia cellsJournal of Chromatography A, 1977
- Antiviral Activity of Arabinosyladenine and Arabinosylhypoxanthine in Herpes Simplex Virus-Infected KB Cells: Selective Inhibition of Viral Deoxyribonucleic Acid Synthesis in the Presence of an Adenosine Deaminase InhibitorAntimicrobial Agents and Chemotherapy, 1976
- Antiviral Activity of Arabinosyladenine and Arabinosylhypoxanthine in Herpes Simplex Virus-Infected KB Cells: Selective Inhibition of Viral Deoxyribonucleic Acid Synthesis in Synchronized Suspension CulturesAntimicrobial Agents and Chemotherapy, 1976